A Study of HDM2012 in Patients With Advanced Solid Tumor

PHASE1RecruitingINTERVENTIONAL

Enrollment

129

Participants

Timeline

Start Date

August 6, 2025

Primary Completion Date

October 31, 2027

Study Completion Date

June 30, 2028

Conditions

Advanced Solid Tumors

Interventions

DRUG

HDM2012

HDM2012 will be administered via IV infusion.

Trial Locations (1)

RECRUITING

Zhongshan Hospital, Fudan University, Shanghai

All Listed Sponsors

lead

Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.

INDUSTRY